首页> 外文期刊>Cerebrovascular diseases >Clinical Effectiveness and Safety Outcomes of Endovascular Treatment for Acute Anterior Circulation Ischemic Stroke in China
【24h】

Clinical Effectiveness and Safety Outcomes of Endovascular Treatment for Acute Anterior Circulation Ischemic Stroke in China

机译:中国急性前循环缺血性脑卒中血管内治疗临床效果及安全性结果

获取原文
获取原文并翻译 | 示例
           

摘要

Backgrounds and Purpose: This study was aimed at investigating the outcomes and predictors for the poor functional outcome after endovascular treatment (EVT) in a large, mostly Asian population. Methods: Between January 2014 and June 2016, acute stroke patients with anterior circulation occlusion and EVT were retrospectively enrolled from 21 stroke centers in China. The main outcomes were modified Rankin Scale (0-2 as functional independence, 3-6 as poor) at 90 days, symptomatic intracranial hemorrhage (sICH) at 72 h, and death at 90 days. Logistic regression was used to identify predictors for poor functional outcome at 90 days. Results: Of the 698 patients, 304 (43.6%) patients had functional independence at 90 days. The sICH rate was 15.5% (108/698) and mortality rate at 90 days was 25.4% (177/698). Age (OR 1.04, 95% CI 1.02-1.07), National Institutes of Health Stroke Scale score at admission (11-20 vs. = 10, OR 2.38, 95% CI 1.23-4.59; = 21 vs. = 10, OR 3.66, 95% CI 1.72-7.80), baseline glucose level (OR 1.09, 95% CI 1.01-1.18), onset to groin puncture 6 h (OR 1.88, 95% CI 1.06-3.31), sICH (OR 15.49, 95% CI 5.16-46.43), and pneumonia (OR 3.15, 95% CI 1.86-5.32) were independent predictors of poor functional outcomes, while good recanalization (OR 0.26, 95% CI 0.13-0.54), preoperative Alberta Stroke Program Early CT Score 8-10 (OR 0.48, 95% CI 0.28-0.83), and good collateral flow (OR 0.50, 95% CI 0.32-0.79) were protective factors. Conclusions: This study provides evidence in real world to support the performance of EVT in acute anterior circulation stroke patients in Chinese population. Patients with small infarct core, successful recanalization, good collateral status, and short treatment delay without sICH or pneumonia may benefit from EVT. (C) 2017 S. Karger AG, Basel
机译:背景和目的:本研究旨在调查血管内治疗(EVT)在大多数亚洲人口的血管内治疗后功能良好的结果和预测因子。方法:2014年1月至2016年6月,急性脑卒中闭塞和EVT的急性脑卒中患者回顾性从中国的21个中风中心注册。在90天,在90天,72小时的症状颅内出血(SICH)和90天死亡,在90天,症状颅内出血(SICH)进行修改规模(0-2。 Logistic回归用于识别90天功能良好的函数结果的预测因子。结果:698例患者,304名(43.6%)患者在90天内具有功能独立性。 SICH率为15.5%(108/698),90天的死亡率为25.4%(177/698)。年龄(或1.04,95%CI 1.02-1.07),入院的国家健康卒中量表评分(11-20对= 10,或2.38,95%CI 1.23-4.59;& = 21 Vs.&lt ; = 10,或3.66,95%CI 1.72-7.80),基线葡萄糖水平(或1.09,95%CI 1.01-1.18),开始腹股沟刺穿& 6小时(或1.88,95%CI 1.06-3.31), Sich(或15.49,95%CI 5.16-46.43)和肺炎(或3.15,95%CI 1.86-5.32)是功能性差的独立预测因子,而术前重新化(或0.26,95%CI 0.13-0.54),术前Alberta Stroke程序早期CT得分8-10(或0.48,95%CI 0.28-0.83),良好的侧支流(或0.50,95%CI 0.32-0.79)是保护因素。结论:本研究提供了现实世界的证据,以支持EVT在中国人口中急性前循环中患者的表现。梗死核心小的患者,成功重新化,良好的抵押品状态和没有SICH或肺炎的短治疗延迟可能会受益于EVT。 (c)2017年S. Karger AG,巴塞尔

著录项

  • 来源
    《Cerebrovascular diseases》 |2017年第6期|共11页
  • 作者单位

    Nanjing Univ Dept Neurol Jinling Hosp Med Sch 305 East Zhongshan Rd Nanjing 210002 Jiangsu;

    Second Mil Med Univ Jinling Hosp Dept Neurol Nanjing Jiangsu Peoples R China;

    Second Mil Med Univ Jinling Hosp Dept Neurol Nanjing Jiangsu Peoples R China;

    Southern Med Univ Jinling Hosp Dept Neurol Nanjing Jiangsu Peoples R China;

    Third Mil Med Univ Daping Hosp Dept Neurol Res Inst Surg Chongqing Peoples R China;

    Zhejiang Prov Peoples Hosp Dept Neurol Hangzhou Zhejiang Peoples R China;

    Fuzhou Gen Hosp Nanjing Mil Reg Dept Neurol Fuzhou Fujian Peoples R China;

    Hubei Zhongshan Hosp Dept Neurol Wuhan Hubei Peoples R China;

    101st Hosp Peoples Liberat Army Dept Neurosurg Wuxi Peoples R China;

    Wannan Med Coll Yijishan Hosp Dept Neurol Wuhu Peoples R China;

    Yangzhou Univ Peoples Hosp Yangzhou 1 Dept Radiol Yangzhou Jiangsu Peoples R China;

    Zhengzhou Univ Affiliated Hosp 1 Dept Neurol Zhengzhou Henan Peoples R China;

    Chinese Armed Police Force Guangdong Armed Police Dept Neurol Guangzhou Guangdong Peoples R;

    Northern Jiangsu Peoples Hosp Dept Intervent Radiol Yangzhou Jiangsu Peoples R China;

    123rd Hosp Peoples Liberat Army Dept Neurol Bengbu Peoples R China;

    Wuhan 1 Hosp Dept Neurol Wuhan Hubei Peoples R China;

    Changsha Cent Hosp Dept Neurol Changsha Hunan Peoples R China;

    Guangdong Prov 2 Peoples Hosp Dept Neurol Guangzhou Guangdong Peoples R China;

    Sichuan Prov Peoples Hosp Dept Neurol Chengdu Sichuan Peoples R China;

    Xiamen Univ Hosp Peoples Liberat Army 175 Affiliated Southeast Hosp Dept Neurol Zhangzhou;

    476th Hosp Peoples Liberat Army Dept Neurol Fuzhou Fujian Peoples R China;

    Hubei Wuchang Hosp Dept Neurol Wuhan Hubei Peoples R China;

    Anhui Med Univ Dept Neurol Luan Affiliated Hosp Luan Peoples R China;

    Soochow Univ Affiliated Hosp 2 Dept Neurol Suzhou Peoples R China;

    Nanjing Univ Dept Med Stat Jinling Hosp Med Sch Nanjing Jiangsu Peoples R China;

    Nanjing Univ Dept Neurol Jinling Hosp Med Sch 305 East Zhongshan Rd Nanjing 210002 Jiangsu;

    Nanjing Univ Dept Neurol Jinling Hosp Med Sch 305 East Zhongshan Rd Nanjing 210002 Jiangsu;

    Nanjing Univ Dept Neurol Jinling Hosp Med Sch 305 East Zhongshan Rd Nanjing 210002 Jiangsu;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 神经病学与精神病学;
  • 关键词

    Endovascular procedures; Stroke; Tissue plasminogen activator; Thrombectomy; Outcome;

    机译:血管内程序;中风;组织纤溶酶原激活剂;血栓切除术;结果;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号